These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study. Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794 [TBL] [Abstract][Full Text] [Related]
6. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes. Blunden M; Zeitlin D; Ashman N; Fan SL Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615 [TBL] [Abstract][Full Text] [Related]
7. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie. Klaus G; Schaefer F; Müller-Wiefel D; Mehls O Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728 [TBL] [Abstract][Full Text] [Related]
8. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319 [TBL] [Abstract][Full Text] [Related]
9. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis. Lee CC; Sun CY; Chang KC; Wu MS Ther Apher Dial; 2010 Apr; 14(2):201-8. PubMed ID: 20438543 [TBL] [Abstract][Full Text] [Related]
10. Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years. Kitterer D; Latus J; Pöhlmann C; Alscher MD; Kimmel M PLoS One; 2015; 10(9):e0135969. PubMed ID: 26405797 [TBL] [Abstract][Full Text] [Related]
11. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Goldberg L; Clemenger M; Azadian B; Brown EA Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167 [TBL] [Abstract][Full Text] [Related]
12. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391 [TBL] [Abstract][Full Text] [Related]
14. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Mars RL; Moles K; Pope K; Hargrove P Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311 [TBL] [Abstract][Full Text] [Related]
15. Effects of a Statewide Protocol for the Management of Peritoneal Dialysis-Related Peritonitis on Microbial Profiles and Antimicrobial Susceptibilities: A Retrospective Five-Year Review. McGuire AL; Carson CF; Inglis TJ; Chakera A Perit Dial Int; 2015 Dec; 35(7):722-8. PubMed ID: 26152579 [TBL] [Abstract][Full Text] [Related]
16. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study . Yang L; Gong N; Zhou H; Jiang J Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821 [TBL] [Abstract][Full Text] [Related]
17. Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis. Rocha A; Rodrigues A; Teixeira L; Carvalho MJ; Mendonça D; Cabrita A Blood Purif; 2012; 33(4):284-91. PubMed ID: 22572743 [TBL] [Abstract][Full Text] [Related]